FDA Approves Cimzia for Rheumatoid Arthritis
Links shared publicly online about this topic
Rheumatoid Arthritis - Biologic Medications for Rheumatoid Arthritis: Cimzia vs. Simponi
healthcentral.com — “With nine biologic medications available to treat rheumatoid arthritis, it can be difficult knowing which to choose and how they compare. Read my previous...” View full resource at healthcentral.com
Most Recently Shared on May 3, 2010 at 2:34 pm By:
Biologic Medications for RA: Cimzia vs. Simponi - With nine biologic medications available to treat rheumatoid arth... http://ow.ly/17fDbf
FDA Approves New Drug For Rheumatoid Arthritis
medicalnewstoday.com — “The u.s. food and drug administration approved actemra (tocilizumab) on friday to treat adults with moderate to severe rheumatoid arthritis who have not adequately responded to or cannot tolerate ” View full resource at medicalnewstoday.com
Most Recently Shared on January 12, 2010 at 4:08 pm By:
MNT Arthritis News Health News
FDA Approves New Drug For Rheumatoid Arthritis http://mnt.to/3wbv
FDA Approves Actemra for Treatment of Rheumatoid Arthritis
emaxhealth.com — “Yesterday, Genetech Inc (a subsidiary of the Roche Group) announced that the U.S. Food and Drug Administration (FDA) has approved Actemra (tocilizuma...” View full resource at emaxhealth.com
Most Recently Shared on January 9, 2010 at 7:00 pm By:
Dr. Kevin Smith Doctor, CAM, and Chiropractor
FDA Approves Actemra for Treatment of Rheumatoid Arthritis ...: Yesterday, Genetech Inc (a subsidiary of the Ro.. http://bit.ly/5oOGXA
FDA Approves Actemra for the Treatment of Moderately to Severely Active Rheumatoid Arthritis
drugs.com — “Actemra (tocilizumab) is used to treat rheumatoid arthritis. Includes Actemra side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on January 12, 2010 at 12:27 am By:
FDA Approves Actemra for the Treatment of Moderately to Severely Active Rheumatoid Arthritis - http://bit.ly/8vWion
FDA Approves Actemra (tocilizumab) for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA)
drugs.com — “Actemra (tocilizumab) is used to treat Rheumatoid Arthritis and Systemic Juvenile Idiopathic Arthritis . Includes Actemra side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on April 19, 2011 at 3:15 am By:
FDA Approves Actemra for the Treatment of Systemic Juvenile Idiopathic Arthritis (SJIA) - http://bit.ly/gKMQJR
Medicine and Technology [part of HCPLive]: FDA approves Actemra (tocilizumab) for rheumatoid arthritis
medicineandtechnology.com — “Medicine and Technology [part of HCPLive]: FDA approves Actemra (tocilizumab) for rheumatoid arthritis” View full resource at medicineandtechnology.com
Most Recently Shared on January 12, 2010 at 4:19 am By:
Joseph Kim, MD, MPH Doctor and Physician
FDA approves Actemra (tocilizumab) for rheumatoid arthritis http://bit.ly/5xmlaz
Cimzia(R) (Certolizumab Pegol) Data Showed Broad And Rapid Relief From Burden Of Symptoms In Rheumatoid Arthritis Patients
medicalnewstoday.com — “UCB announced results from a post hoc analysis of the RAPID 2 study, published in the Annals of Rheumatic Diseases, which showed Cimzia®, the only approved PEGylated anti-TNF, plus meth” View full resource at medicalnewstoday.com
Most Recently Shared on May 10, 2011 at 2:31 pm By:
Cimzia(R) (Certolizumab Pegol) Data Showed Broad And Rapid Relief From Burden Of Symptoms In Rheumatoid Arthriti... http://bit.ly/kqPo3P
The IN VIVO Blog: FDA Gives Cimzia the Thumbs Up in RA—At Last
invivoblog.blogspot.com — “The IN VIVO Blog: FDA Gives Cimzia the Thumbs Up in RA—At Last” View full resource at invivoblog.blogspot.com
Most Recently Shared on May 14, 2009 at 2:50 pm By:
Chris Morrison Health Communicator
Melanie Senior's take on Cimzia RA approval up on IVB, with bonus pic of delicious Belgian beer. http://tinyurl.com/qxj92o
Patient access scheme secures NICE approval for Cimzia | InPharm
inpharm.com — “Patient access scheme secures NICE approval for Cimzia | InPharm” View full resource at inpharm.com
Most Recently Shared on January 22, 2010 at 2:45 pm By:
Pharmafocus Health News and Pharma
Patient access scheme secures NICE approval for Cimzia. UCB’s RA drug passed after deal with Department of Health. http://ow.ly/ZkTe
New FDA approved drug battles rheumatoid arthritis | KDRV
kdrv.com — “New FDA approved drug battles rheumatoid arthritis | KDRV” View full resource at kdrv.com
Most Recently Shared on September 23, 2010 at 2:33 am By:
New FDA approved drug battles rheumatoid arthritis: RA destroys the cartilage and bone around the joint, and can o... http://bit.ly/ae7AWP
FDA Approves New Drug for Moderate to Severe Rheumatoid Arthritis
seniorjournal.com — “Jan. 12, 2010 - The U.S. Food and Drug Administration has approved Actemra (tocilizumab) to treat adults with moderate to severe rheumatoid arthritis who have not adequately responded to or cannot tolerate other approved drug classes for rheumatoid arthritis. The majority of America's 1.3 million RA patients are senior citizens with the average age for all RA victims being 66.8 years. Alerts for senior citizens and baby boomers.” View full resource at seniorjournal.com
Most Recently Shared on January 22, 2010 at 9:30 pm By:
Steve Jorgenson Health Executive
FDA Approves New Drug for Moderate to Severe Rheumatoid Arthritis http://ow.ly/XRAm
FDA Approves Rheumatoid-Arthritis Drug - WSJ.com
online.wsj.com — “The FDA approved a new type of drug by Roche Holding's Genentech unit to treat rheumatoid arthritis in patients who have failed other treatments.” View full resource at online.wsj.com
Most Recently Shared on January 9, 2010 at 2:41 am By:
FDA Approves Rheumatoid-Arthritis Drug http://bit.ly/5wA28r
Medical News: FDA Okays Certolizumab Pegol for Rheumatoid Arthritis - in Geriatrics, Arthritis from MedPage Today
medpagetoday.com — “LITTLE FALLS, N.J. -- Certolizumab pegol (Cimzia) has been approved by the FDA for adult patients with moderately to severely active rheumatoid arthritis, the maker of the drug announced.” View full resource at medpagetoday.com
Most Recently Shared on May 14, 2009 at 4:46 pm By:
FDA Okays Certolizumab Pegol for Rheumatoid Arthritis http://medpagetoday.com/14210
Subcutaneous Formulation of Orencia Approved for Rheumatoid Arthritis - MPR
empr.com — “The FDA has approved a subcutaneous formulation of Orencia (abatacept; Bristol-Myers Squibb) for the reduction of signs and symptoms in adults with moderate to severe rheumatoid arthritis (RA).” View full resource at empr.com
Most Recently Shared on August 1, 2011 at 2:49 pm By:
MPR News: Subcutaneous Formulation of Orencia Approved for Rheumatoid Arthritis: The FDA has approved a subcutan... http://bit.ly/njnX58
FDA Approves ACTEMRA(R) (tocilizumab) For The Treatment Of Moderately To Severely Active Rheumatoid Arthritis
medicalnewstoday.com — “Genentech, inc., a wholly owned member of the roche group (six: ro, rog; otcqx: rhhby), today announced that the u.s. food and drug administration (fda) approved actemra® (tocilizumab) for the” View full resource at medicalnewstoday.com
Most Recently Shared on January 11, 2010 at 5:07 pm By:
MNT Arthritis News Health News
FDA Approves ACTEMRA(R) (tocilizumab) For The Treatment Of Moderately To Severely Active Rheumatoid Arthritis http://mnt.to/3w8r
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
Lisa Emrich
Patient Advocate and Blogger, Living with Multiple Sclerosis and Rheumatoid Arthritis, Musician, Educator, and writer for HealthCentral.com
-
MNT Arthritis News
The latest arthritis / rheumatology news published daily. Articles from research centers, universities and prestigious journals.
-
Dr. Kevin Smith
I'm a doctor of chiropractic with a focus in spinal rehabilitation, brain based therapies and functional medicine. 412-212-8880
Advertisement
